Markets › India › NSE › CAPLIPOINT

Caplin Point Laboratories Ltd

NSE:CAPLIPOINTHealthcareNSE:CNX500NSE:NIFTY500_EW

₹2,258.80−1.85%At closeAt close · Mon 19 Oct · ≈ AED 87.15 · Market cap $1.84B · Next earnings Thu 5 Nov

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	54.8%	55.0%	53.7%	55.4%	58.7%	48.0%	—	—
Operating margin	40.0%	41.2%	40.1%	42.6%	45.5%	31.5%	31.5%	+0.0 pts
Net margin	22.8%	23.6%	25.6%	26.9%	27.7%	29.3%	29.3%	+0.0 pts
EBITDA margin	30.9%	31.0%	30.0%	32.5%	33.4%	40.1%	—	—
Return on equity	20.4%	20.2%	20.0%	19.7%	18.8%	17.9%	17.7%	−0.2 pts
Return on assets	17.8%	17.3%	17.2%	16.9%	16.7%	15.9%	15.9%	+0.0 pts
Return on capital employed	34.8%	34.3%	30.6%	30.5%	30.4%	18.8%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	−1.2%
Debt / assets	1.3%	0.1%	0.3%	0.1%	0.2%	0.1%	—	—
Interest coverage	267.6×	748.4×	754.9×	926.3×	1,448.1×	790.9×	—	—
Current ratio	7.1×	6.2×	5.8×	5.7×	7.0×	6.7×	6.7×	+0.0%
Quick ratio	5.8×	5.2×	4.7×	4.6×	5.9×	5.6×	—	—
Cash ratio	3.2×	2.2×	0.7×	1.7×	1.9×	1.6×	1.6×	+0.0%
Asset turnover	0.8×	0.7×	0.7×	0.6×	0.6×	0.5×	—	—
Inventory turnover	2.7×	2.5×	2.4×	2.1×	2.4×	2.7×	—	—
Receivables turnover	2.7×	2.5×	2.7×	2.6×	3.1×	2.6×	—	—
Dividend payout	1.2%	7.6%	8.1%	7.5%	7.1%	7.1%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.